Filter Results :

Your search for Biosimilars returned 49 reports

Sort by


EMEA (Europe, Middle East and Africa) Biologics and Biosimilars Market Report 2017

10 May 2017  |  Published by:  QYResearch
In this report, the EMEA Biologics and Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), ...

$ 4,000.00

Read More

Global Biologics and Biosimilars Market Research Report 2017

20 Apr 2017  |  Published by:  QYResearch
In this report, the global Biologics and Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption,...

$ 2,900.00

Read More

Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs Breast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market

01 Apr 2017  |  Published by:  GBI Research
SummaryRheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects the joints. It is characterized by synovial inflammation and gradual bone erosion over many years. Disease progression results in stiffness and pain, especially in the hands a...

$ 4,995.00

Read More

Biosimilars in Emerging Markets (2017)

01 Mar 2017  |  Published by:  FirstWord
Biosimilars: Make the most of high risk emerging market opportunities Emerging biosimilars markets are currently a $5billion opportunity with even more growth potential ahead. Lower drug costs and improved patient access are attractive to governments, insurers and patients too. But with market regul...

$ 2,245.00

Read More

Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets

01 Mar 2017  |  Published by:  GBI Research
SummaryThe cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life. The key indications covere...

$ 4,995.00

Read More

Biosimilars: US Payer Perspectives (2017)

01 Mar 2017  |  Published by:  FirstWord
Will biosimilar provide a ‘magic bullet’ to drug prices in the US? Payers speak out… Biosimilars continue to be big business in the US, but has progress has been too slow? Not so, argue payers. While the number of biosimilar approvals in the US still lags behind Europe, a solid foundation continues ...

$ 2,245.00

Read More

Biosimilars: European Payer Perspectives

01 Feb 2017  |  Published by:  FirstWord
What is the future for biosimilars in the EU?What issues do EU Payers think will impact adoption, pricing and reimbursement of biosimilars?In January 2016 Samsung Bioepis launched Benepali, a biosimilar version of Enbrel marking a significant advance in biosimilar therapy options.  With biosimi...

$ 2,245.00

Read More

Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CMO), Application (Oncology, Blood Disorders) - Global Forecast to 2021

05 Jan 2017  |  Published by:  MarketsandMarkets
The global biosimilars market is expected to reach USD 10.90 billion by 2021 from USD 3.39 billion in 2016, at a CAGR of 26.3%. The biosimilars market is broadly classified into product, manufacturing type, application, and region. On the basis of product, the biosimilars market is segmented into re...

$ 5,650.00

Read More

2016 Global Biosimilars Market Status, 2011-2022 Market Historical and Forecasts, Professional Market Research Report

20 Dec 2016  |  Published by:  Tuoda Research
This New Version Biosimilars Market Research Report is a deep market research report in this market.This report focused on global and regional market, major manufacturers, as well as the segment market details on different classifications and applications.First, this report analyzed the basic scope ...

$ 2,800.00

Read More

2017 Top 5 Biologics and Biosimilars Manufacturers in North America, Europe, Asia-Pacific, South America, Middle East and Africa

07 Dec 2016  |  Published by:  LP INFORMATION
This report studies Biologics and Biosimilars in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top Biologics and Biosimilars Players in each region, with sales, price, revenue and market share for top manufacturer, covering- R...

$ 4,960.00
$ 4,464.00
( Save 10% )

Read More

2017-2022 Global Top Countries Biologics and Biosimilars Market Report

07 Dec 2016  |  Published by:  LP INFORMATION
This report studies Biologics and Biosimilars in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle East and Africa, focuses on the top Manufacturers in each country, covering- Roche- A...

$ 4,960.00
$ 4,464.00
( Save 10% )

Read More

amp biosimilars AG (1YA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

21 Nov 2016  |  Published by:  GlobalData
Summaryamp biosimilars AG (amp biosimilars) develops biosimilars. Its product pipeline includes four biosimilar development projects focusing on immune disorders and cancer. The company focuses on therapeutic areas that include cancer, autoimmune and inflammatory diseases. The company offers a resea...

$ 250.00

Read More

Global Biosimilars And Follow-On Biologics Market Research Report 2016

12 Nov 2016  |  Published by:  9Dimen Research
2016 Global Biosimilars And Follow-On Biologics Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Biosimilars And Follow-On Biologics industry, focusing on the main regions (North America, Europe and Asia) and the main countries (Un...

$ 2,850.00

Read More

Global Oncology Biosimilars Market Research Report 2016

15 Oct 2016  |  Published by:  S&P Consulting
The global oncology biosimilars market will witness substantial growth over the forecast period and is expected to grow at very impressive CAGR during the forecast period. The increasing need for cost-effective treatment methodologies will aid in the stable growth of this market during the forecast ...

$ 2,800.00

Read More

Global Oncology Biosimilars Sales Market Report 2016

15 Oct 2016  |  Published by:  S&P Consulting
The global oncology biosimilars market will witness substantial growth over the forecast period and is expected to grow at very impressive CAGR during the forecast period. The increasing need for cost-effective treatment methodologies will aid in the stable growth of this market during the forecast ...

$ 3,800.00

Read More
Total 49 records.